Brain site-specific gene expression analysis in Alzheimer's disease patients.
about
The reticulons: a family of proteins with diverse functionsDeficiency of the E3 ubiquitin ligase TRIM32 in mice leads to a myopathy with a neurogenic componentProteomics in Traditional Chinese Medicine with an Emphasis on Alzheimer's DiseaseThe Ubiquitin-Proteasome System and Molecular Chaperone Deregulation in Alzheimer's DiseaseCharacterizing the novel protein p33MONOXIdentification and characterisation of the novel amyloid-beta peptide-induced protein p17P60TRP interferes with the GPCR/secretase pathway to mediate neuronal survival and synaptogenesisHeat shock protein responses to aging and proteotoxicity in the olfactory bulb.Heat shock proteins in neurodegenerative disorders and agingThe neural stem cell fate determinant TRIM32 regulates complex behavioral traits.Human mitochondrial transcriptional factor A breaks the mitochondria-mediated vicious cycle in Alzheimer's disease.Locus coeruleus cellular and molecular pathology during the progression of Alzheimer's disease.First evidence of overlaps between HIV-Associated Dementia (HAD) and non-viral neurodegenerative diseases: proteomic analysis of the frontal cortex from HIV+ patients with and without dementia.Expression of reticulon 3 in Alzheimer's disease brain.Heat shock protein 90 in Alzheimer's diseaseThe novel protein MANI modulates neurogenesis and neurite-cone growth.Amyloid-β oligomers induce differential gene expression in adult human brain slices.TRIM32-Cytoplasmic-Body Formation Is an ATP-Consuming Process Stimulated by HSP70 in Cells.Ubiquitylation by Trim32 causes coupled loss of desmin, Z-bands, and thin filaments in muscle atrophyTripartite motif ligases catalyze polyubiquitin chain formation through a cooperative allosteric mechanism.Tripartite containing motif 32 modulates proliferation of human neural precursor cells in HIV-1 neurodegenerationTripartite motif 32 prevents pathological cardiac hypertrophyInterleukin-6 and neural stem cells: more than gliogenesis.Proteomics-determined differences in the concanavalin-A-fractionated proteome of hippocampus and inferior parietal lobule in subjects with Alzheimer's disease and mild cognitive impairment: implications for progression of AD.Brain site-specific proteome changes in aging-related dementia.Trim32 reduces PI3K-Akt-FoxO signaling in muscle atrophy by promoting plakoglobin-PI3K dissociation.The role of reticulons in neurodegenerative diseases.Upregulated Expression of TRIM32 Is Involved in Schwann Cell Differentiation, Migration and Neurite Outgrowth After Sciatic Nerve Crush.The protein p17 signaling pathways in cancer.TRIM32 affects the recovery of motor function following spinal cord injury through regulating proliferation of glia.Suppression of Trim32 Enhances Motor Function Repair after Traumatic Brain Injury Associated with Antiapoptosis.Deletion of TRIM32 protects mice from anxiety- and depression-like behaviors under mild stress.Characterization of the novel protein P9TLDR (temporal lobe down-regulated) with a brain-site-specific gene expression modality in Alzheimer's disease brain.The ubiquitin ligase tripartite-motif-protein 32 is induced in Duchenne muscular dystrophy.
P2860
Q21184131-3026AD30-F5ED-46DE-979B-EE1B370CBB4EQ24656031-1BCC09FB-4714-4C0B-A2AD-57E8FAFF1E3DQ26777933-068E43C9-4CA8-42BD-8D60-6D693D2F9E53Q28254943-ADE3A867-84DD-4471-8178-1D4995CDC56FQ28509587-B7856993-C52C-49D5-AAB5-5673536A2506Q28568098-3888366C-2ABE-4872-B14D-3734607062F5Q28589363-CA4E8204-949A-4C19-8E4D-0ED565B961CEQ30382422-2D114C5B-BF81-4922-9AB3-A1A2214CC64CQ30414556-45545CF1-CF74-4035-B964-8265D0B148EBQ30629154-AF5B0FBD-5AA6-4904-9DAA-CF22A67C0C50Q30830038-5A0DA781-3C29-4AA8-A775-0DB88181DB1FQ30835713-3DFB773F-DDCA-4BE5-BA9E-7A59A699CA1FQ33995872-30A966EF-FCAC-41BA-92F9-AB5AC119C047Q34092787-E9A100C8-26EE-4A6A-A5D5-7E6C1FC90B81Q34413279-EFC9750D-3A1B-44F2-AC18-9FA5158425C7Q35216151-8C0520D3-B543-4678-A186-8AADDD66AC66Q35802078-C3EDD477-0B0E-4B00-AB35-40D125702CF9Q36239507-125DEC73-4301-4F7F-93F5-47DFEAE120AAQ36444247-6A658150-D4DE-49BB-9EC3-418BA170A212Q36708525-DDBB5E37-6A39-44AE-B82B-371B492C184DQ36799270-0FD92FE6-8AB5-46B6-B26E-3D13A6E9B1F0Q36842050-236086BD-DF80-4689-9F25-8FEA403A536BQ37035175-872E2EE9-67CB-42ED-BC3C-0CA888E3DE63Q37135431-0C28BA07-5E6A-4FAE-A230-52336E235FCEQ37212178-5807FD71-565A-417C-BF0F-2B4B1FC637BFQ37614832-5654C3E8-1F73-4328-B307-59C2A168843AQ38161870-EEA4A8BB-846C-4333-A7A2-88372D1A0990Q38724164-C2AD13A0-02BE-44BB-B8C8-FE6B12F66406Q39117690-94D1F073-E380-418E-BF5A-9E304CA00F7DQ41233395-2AA5D0D1-9C84-4F88-A313-49F87C3BAA6DQ47136021-FE3F595B-B1D5-4A7E-8BC6-E78E9BFF745DQ47874474-8DE38F33-8F31-422F-AFE1-153043BEDB9CQ48291296-176EDDE5-4595-4B0F-B96D-7E4CE5F9DFFFQ51705719-36A4ECCF-123F-4C57-9244-986EEAE21B47
P2860
Brain site-specific gene expression analysis in Alzheimer's disease patients.
description
2006 nî lūn-bûn
@nan
2006 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Brain site-specific gene expression analysis in Alzheimer's disease patients.
@ast
Brain site-specific gene expression analysis in Alzheimer's disease patients.
@en
Brain site-specific gene expression analysis in Alzheimer's disease patients.
@nl
type
label
Brain site-specific gene expression analysis in Alzheimer's disease patients.
@ast
Brain site-specific gene expression analysis in Alzheimer's disease patients.
@en
Brain site-specific gene expression analysis in Alzheimer's disease patients.
@nl
prefLabel
Brain site-specific gene expression analysis in Alzheimer's disease patients.
@ast
Brain site-specific gene expression analysis in Alzheimer's disease patients.
@en
Brain site-specific gene expression analysis in Alzheimer's disease patients.
@nl
P2093
P2860
P1476
Brain site-specific gene expression analysis in Alzheimer's disease patients.
@en
P2093
Miyauchi T
Yamamoto T
P2860
P304
P356
10.1111/J.1365-2362.2006.01722.X
P577
2006-11-01T00:00:00Z